ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 13 (4) 1147 -1158     DOI: 10.1677/erc.1.01250
Copyright © 2006 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arroyo-Helguera, O
Right arrow Articles by Aceves, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arroyo-Helguera, O
Right arrow Articles by Aceves, C

Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line

O Arroyo-Helguera, B Anguiano, G Delgado and C Aceves

Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla Km 15 Carretera Qro-SLP, Juriquilla, 76230 Querétaro, México

(Requests for offprints should be addressed to C Aceves; Email: caracev{at}servidor.unam.mx)

This study analyzes the uptake and antiproliferative effect of two different chemical forms of iodine, iodide (I) and molecular iodine (I2), in MCF-7 cells, which are inducible for the Na+/I symporter (NIS) and positive for pendrin (PDS). The mouse fibroblast cell line NIH3T3 was used as control. Our results show that in MCF-7 cells, I uptake is sustained and dependent on NIS, whereas I2 uptake is transient with a maximal peak at 10 min and a final retention of 10% of total uptake. In contrast, no I was taken up by NIH3T3 cells, and although I2 was captured with the same time pattern as in MCF-7 cells, its uptake was significantly lower, and it was not retained within the cell. The uptake of I2 is independent of NIS, PDS, Na+, and energy, but it is saturable and dependent on protein synthesis, suggesting a facilitated diffusion system. Radioiodine was incorporated into protein and lipid fractions only with I2 treatment. The administration of non-radiolabeled I2 and 6-iodo-5-hydroxy-8,11,14-eicosatrienoic acid (6-iodolactone, an iodinated arachidonic acid), but not KI, significantly inhibited proliferation of MCF-7 cells. Proliferation of NIH3T3 cells was not inhibited by 20 µM I2. In conclusion, these results demonstrate that I2 uptake does not depend on NIS or PDS; they suggest that in mammary cancer cells, I2 is taken up by a facilitated diffusion system and then covalently bound to lipids or proteins that, in turn, inhibit proliferation.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
O Arroyo-Helguera, E Rojas, G Delgado, and C Aceves
Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects
Endocr. Relat. Cancer, December 1, 2008; 15(4): 1003 - 1011.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.